Xu, Chun-Fang <br/><br/>
Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jun 2011 
 - 2557-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2010.32.9110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Carcinoma, Renal Cell--drug therapy<br/>Clinical Trials, Phase II as Topic--statistics & numerical data<br/>Cross-Over Studies<br/>DNA Mutational Analysis<br/>Disease-Free Survival<br/>Genetic Markers<br/>Genotype<br/>Germ-Line Mutation<br/>Humans<br/>Indazoles<br/>Kidney Neoplasms--drug therapy<br/>Multicenter Studies as Topic--statistics & numerical data<br/>Neoplasm Proteins--genetics<br/>Neovascularization, Physiologic--genetics<br/>Polymorphism, Single Nucleotide<br/>Proportional Hazards Models<br/>Pyrimidines--pharmacology<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Sulfonamides--pharmacology